Genetic Analysis Techniques News and Research

RSS

NCI awards UAMS Myeloma Institute $19.5M grant

The internationally known multiple myeloma program at the University of Arkansas for Medical Sciences (UAMS) will receive $19.5 million over five years to continue work that has already developed new treatments for this cancer of plasma cells, a type of white blood cell present in the bone marrow.

28 Oct 2009

Helicos Biosciences reports operational highlights for the third quarter of 2009

Helicos BioSciences Corporation announced today its operational, technical and scientific highlights for the quarter ended September 30, 2009.

27 Oct 2009

Intellectual property covering compounds that have utility in treating SMA licensed

Repligen Corporation announced today that it has entered into an exclusive license agreement with Families of Spinal Muscular Atrophy (FSMA) for intellectual property covering compounds which may have utility in treating Spinal Muscular Atrophy (SMA).

23 Oct 2009

Genes to determine which rectal cancer patient can avoid surgical procedure for treatment

A set of 87 genes one day may be used to routinely determine which patients can be successfully treated for advanced rectal cancer without undergoing a surgical procedure, researchers announced at the 2009 Clinical Congress of the American College of Surgeons.

15 Oct 2009

Marker genes help determine the effectiveness of targeted molecular drug regimen for treating GIST

Analysis of a small number of marker genes may determine in a matter of hours if a patient with gastrointestinal stromal tumors (GIST) would respond to a targeted molecular drug regimen. This analysis could allow clinicians to determine if they have chosen the best course of action or need to consider another alternative.

15 Oct 2009

Nano Gen Teknolojileri to distribute Fluidigm's BioMark and EP1 genetic analysis systems in Turkey

Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Nano Gen Teknolojileri Ltd. as its exclusive distributor for the BioMark™ and EP1™ Systems for genetic analysis in Turkey. The BioMark System provides significant advantages for digital and real-time PCR, genotyping, single-cell gene expression, cancer detection and absolute quantification.

15 Oct 2009

Transgenomic adds DFCI's Cold-PCR mutation detection technology to its portfolio

Transgenomic, Inc. (OTC Bulletin Board: TBIO). The company announced today that it has licensed a high-sensitivity mutation detection technology called Cold-PCR from the Dana-Farber Cancer Institute (DFCI), Boston, MA.

9 Oct 2009

Helicos Biosciences awarded a $2.9M NIH grant

Helicos BioSciences Corporation announced today that it is the recipient of an award from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH).

8 Oct 2009

The CE Marked HairDX Genetic Test for Hair Loss launched in Europe

The HairDX Genetic Test for Hair Loss, the world’s first genetic baldness (Androgenetic Alopecia) test, is now available as a CE Marked product under the European In Vitro Diagnostic Directive.

8 Oct 2009

Johns Hopkins researchers identify several genetic links to autism

About 90 percent of autism spectrum disorders have suspected genetic causes but few genes have been identified so far. Now, leading an international team, Johns Hopkins researchers have identified several genetic links to autism, chief among them a variant of semaphorin 5A, whose protein product controls nerve connections in the brain.

8 Oct 2009

NHGRI awards Geospiza a SBIR grant to develop software systems for detecting rare mutations

Geospiza, Inc., the market leading developer of genetic analysis software, today announced the receipt of a Phase I SBIR grant for “Software Systems for Detecting Rare Mutations” from the National Human Genome Research Institute (1R43HG005297-01).

7 Oct 2009

Biology and geography scientists explain the spread of HIV-1 epidemic in Africa

Scientists studying biology and geography may seem worlds apart, but together they have answered a question that has defied explanation about the spread of the HIV-1 epidemic in Africa.

1 Oct 2009

U.S. patent for Idaho Technology’s high resolution nucleic acid melting techniques

Idaho Technology’s patent portfolio continues to grow as the U.S. Patent and Trademark Office granted the company U.S. Patent No. 7,582,429 relating to methods of performing genetic analysis in the presence of a double-stranded nucleic acid binding dye.

30 Sep 2009

Correlagen Diagnostics to develop diagnostic tests on the Helicos Genetic Analysis Platform

Helicos BioSciences Corporation (NASDAQ: HLCS) today announced the sale of a system and a scientific collaboration with Correlagen Diagnostics Inc., a leading provider of genetic tests for disease diagnosis.

28 Sep 2009

Correlagen to use Helicos Genetic Analysis System for diagnosing genetic disorders

Correlagen Diagnostics Inc., a leading provider of genetic testing for disease diagnosis, today announced the acquisition of a system from and a scientific collaboration with Helicos BioSciences Corporation.

28 Sep 2009

Direct RNA sequencing performed using Helicos’ True Single Molecule Sequencing technology

Helicos BioSciences Corporation a life science company focused on innovative genetic analysis technologies, today announced the publication of a landmark study in which Helicos’ True Single Molecule Sequencing (tSMS)™ technology was used to directly sequence individual molecules of RNA. The paper appeared yesterday in the on-line edition of Nature and will appear in an upcoming 2009 print issue of Nature.

24 Sep 2009

Symposium on genetics of psoriasis and psoriatic arthritis to be held

A symposium about “Pharmacogenomics In Dermatology And Cosmetics” will be presented on Thursday, October 8 to coincide with the 18th European Academy of Dermatology and Venereology (EADV) Congress. It will be held at the Kempinski Hotel Bristol - Salon Charlottenburg-Cecilienhof, Kurfürstendamm 27, D-10719, Berlin, Germany.

24 Sep 2009

Technological and scientific initiatives from Helicos BioSciences Corporation

Helicos BioSciences Corporation provided updates on recent scientific findings and progress on Helicos’s technology initiatives. Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the CHI Next Generation Sequencing conference in Providence, RI, Patrice Milos, Ph.D. Vice President and Chief Scientific Officer provided an overview of recent technological and scientific initiatives underway at Helicos.

23 Sep 2009

Advanced Hair Studio to introduce genetic baldness tests in Australia

Men and women in Australia now have access to genetic tests for predicting the risk of male or female hair loss thanks to a distribution agreement announced today by pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC. (www.hairdx.com)

23 Sep 2009

Helicos Biosciences to raise $10 million through private placement

Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement with certain new and existing investors, including Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures (the “Existing Investors”) and Ron Lowy, the Company’s chief executive officer, to raise approximately $10 million in gross proceeds in a private placement through the sale of shares of its common stock and warrants.

17 Sep 2009

Genetic Analysis Techniques News and Research

NCI awards UAMS Myeloma Institute $19.5M grant

Helicos Biosciences reports operational highlights for the third quarter of 2009

Intellectual property covering compounds that have utility in treating SMA licensed

Genes to determine which rectal cancer patient can avoid surgical procedure for treatment

Marker genes help determine the effectiveness of targeted molecular drug regimen for treating GIST

Nano Gen Teknolojileri to distribute Fluidigm's BioMark and EP1 genetic analysis systems in Turkey

Transgenomic adds DFCI's Cold-PCR mutation detection technology to its portfolio

Helicos Biosciences awarded a $2.9M NIH grant

The CE Marked HairDX Genetic Test for Hair Loss launched in Europe

Johns Hopkins researchers identify several genetic links to autism

NHGRI awards Geospiza a SBIR grant to develop software systems for detecting rare mutations

Biology and geography scientists explain the spread of HIV-1 epidemic in Africa

U.S. patent for Idaho Technology’s high resolution nucleic acid melting techniques

Correlagen Diagnostics to develop diagnostic tests on the Helicos Genetic Analysis Platform

Correlagen to use Helicos Genetic Analysis System for diagnosing genetic disorders

Direct RNA sequencing performed using Helicos’ True Single Molecule Sequencing technology

Symposium on genetics of psoriasis and psoriatic arthritis to be held

Technological and scientific initiatives from Helicos BioSciences Corporation

Advanced Hair Studio to introduce genetic baldness tests in Australia

Helicos Biosciences to raise $10 million through private placement

Genetics & Genomics - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News